Multivitamins Show No Link To 'Lower Risk of Death,' Study Finds
Multivitamins Show No Link To 'Lower Risk of Death,' Study Finds
Taking a multivitamin once a day has long been considered a path to better health, but a new study refutes that widely held belief.
长期以来，每天服用一次综合维生素被认为是通往更健康的道路，但一项新研究驳斥了这一普遍信仰。
A study published in JAMA Network Open on Wednesday revealed that after tracking nearly 400,000 healthy adults for over 20 years, researchers found no link between regular multivitamin use and a lower risk of death, according to the National Institutes of Health.
根据国家卫生研究院的一项研究，周三在JAMA Network Open上发表的一项研究发现，在跟踪近40万名健康成年人20多年后，研究人员发现，定期服用综合维生素与较低死亡风险之间没有关联。
The study was led by researchers at the National Institutes of Health's National Cancer Institute.
该研究由国家卫生研究院的国家癌症研究所的研究人员领导。
Also Read: Healthcare Advocates United: A Push For Congress To Recognize CBD As Dietary Supplements
还阅读过：医疗保健倡导者团结一致：推动国会承认CBD为膳食补品
"The analysis showed that people who took daily multivitamins did not have a lower risk of death from any cause than people who took no multivitamins," Erikka Loftfield, Ph.D., M.P.H., a researcher with the division of cancer epidemiology and genetics at the National Cancer Institute, wrote in the study.
“分析显示，每天服用综合维生素的人死于任何原因的风险不比不服用综合维生素的人低，”国家癌症研究所癌症流行病学和遗传学分部的研究员Erikka Loftfield博士、公共卫生硕士在研究中写道。
"There were also no differences in mortality from cancer, heart disease, or cerebrovascular diseases. The results were adjusted for factors such as race and ethnicity, education, and diet quality."
“在癌症、心脏病或脑血管疾病的死亡率方面也没有差异。该结果已调整为因素，如种族和民族、教育和饮食质量。”
Loftfield also emphasized the importance of assessing the risk of death associated with multivitamin use in different populations, such as those with documented nutritional deficiencies. She highlighted the need to explore the potential impact of regular multivitamin use on aging-related health conditions.
Loftfield还强调了在不同人群中评估与综合维生素使用相关的死亡风险的重要性，例如那些存在营养缺乏的人群。她强调了探索定期服用综合维生素对与年龄相关的健康状况的潜在影响的必要性。
Price Action: Despite the study's findings on multivitamin use, related health and wellness companies saw varied market reactions. By Thursday's afternoon trading, BellRing Brands, Inc. (NYSE:BRBR) gained 1.08% to $57.89, Herbalife Ltd. (NYSE:HLF) slipped 1.03% to $10.52, and USANA Health Sciences, Inc. (NYSE:USNA) was up 1% to $45.44.
价格走势：尽管该研究发现综合维生素的使用情况，相关的健康和福祉公司看到了不同的市场反应。截至周四下午交易，BellRing Brands, Inc. (纽交所:BRBR) 上涨1.08%，至57.89美元，康宝莱有限公司 (纽交所:HLF) 下跌1.03%，至10.52美元，赛百味健康科学公司 (纽交所:USNA) 上涨1%，至45.44美元。
Invesco S&P SmallCap Consumer Staples ETF (NASDAQ:PSCC) slipped 0.09% by early afternoon, while VegTech Plant-based Innovation & Climate ETF (NYSE:EATV) remained unchanged and Invesco Food & Beverage ETF (NYSE:PBJ) declined 0.68%.
早盘，英寿标普小型消费者稳定收益ETF (纳斯达克:PSCC) 下跌0.09%，而VegTech植物为基础的创新与气候ETF (纽交所:EATV) 保持不变，英寿食品与饮料ETF (纽交所:PBJ) 下跌0.68%。
- Gianni Di Poce Rings The Bell On BellRing Brands, Calls For 42% Returns
- Gianni Di Poce为BellRing Brands敲响钟声，呼吁获得42%的回报。
Photo: Shutterstock
Photo: shutterstock